Cargando…
Aberrant B Cell Signaling in Autoimmune Diseases
Aberrant B cell signaling plays a critical in role in various systemic and organ-specific autoimmune diseases. This is supported by genetic evidence by many functional studies in B cells from patients or specific animal models and by the observed efficacy of small-molecule inhibitors. In this review...
Autores principales: | Corneth, Odilia B. J., Neys, Stefan F. H., Hendriks, Rudi W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654300/ https://www.ncbi.nlm.nih.gov/pubmed/36359789 http://dx.doi.org/10.3390/cells11213391 |
Ejemplares similares
-
Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
por: Neys, Stefan F. H., et al.
Publicado: (2021) -
B Cell Signaling and Activation in Autoimmunity
por: Hendriks, Rudi W., et al.
Publicado: (2023) -
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
por: Neys, Stefan F. H., et al.
Publicado: (2021) -
Aberrant B Cell Receptor Signaling in Naïve B Cells from Patients with Idiopathic Pulmonary Fibrosis
por: Neys, Stefan F. H., et al.
Publicado: (2021) -
Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren’s Syndrome Patients at Diagnosis
por: Neys, Stefan F. H., et al.
Publicado: (2022)